DK0496818T3 - IgA-receptor-specifikt monoklonalt antistof - Google Patents

IgA-receptor-specifikt monoklonalt antistof

Info

Publication number
DK0496818T3
DK0496818T3 DK90916618T DK90916618T DK0496818T3 DK 0496818 T3 DK0496818 T3 DK 0496818T3 DK 90916618 T DK90916618 T DK 90916618T DK 90916618 T DK90916618 T DK 90916618T DK 0496818 T3 DK0496818 T3 DK 0496818T3
Authority
DK
Denmark
Prior art keywords
monoclonal antibody
specific monoclonal
iga receptor
iga
receptor
Prior art date
Application number
DK90916618T
Other languages
English (en)
Inventor
Li Shen
Michael W Fanger
Original Assignee
Dartmouth College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dartmouth College filed Critical Dartmouth College
Application granted granted Critical
Publication of DK0496818T3 publication Critical patent/DK0496818T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against Fc-receptors, e.g. CD16, CD32, CD64
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C07K16/468—Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK90916618T 1989-10-20 1990-10-19 IgA-receptor-specifikt monoklonalt antistof DK0496818T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42488389A 1989-10-20 1989-10-20
PCT/US1990/006030 WO1991005805A1 (en) 1989-10-20 1990-10-19 MONOCLONAL ANTIBODY SPECIFIC FOR IgA RECEPTOR

Publications (1)

Publication Number Publication Date
DK0496818T3 true DK0496818T3 (da) 1999-11-22

Family

ID=23684271

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90916618T DK0496818T3 (da) 1989-10-20 1990-10-19 IgA-receptor-specifikt monoklonalt antistof

Country Status (9)

Country Link
US (1) US5610057A (da)
EP (1) EP0496818B1 (da)
JP (1) JPH05504677A (da)
AT (1) ATE181558T1 (da)
CA (1) CA2067244C (da)
DE (1) DE69033181T2 (da)
DK (1) DK0496818T3 (da)
ES (1) ES2132072T3 (da)
WO (1) WO1991005805A1 (da)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6018031A (en) * 1989-10-20 2000-01-25 Trustees Of Dartmouth College Binding agents specific for IgA receptor
US5582996A (en) * 1990-12-04 1996-12-10 The Wistar Institute Of Anatomy & Biology Bifunctional antibodies and method of preparing same
US6465253B1 (en) 1994-09-08 2002-10-15 Genvec, Inc. Vectors and methods for gene transfer to cells
US5559099A (en) * 1994-09-08 1996-09-24 Genvec, Inc. Penton base protein and methods of using same
US5846782A (en) 1995-11-28 1998-12-08 Genvec, Inc. Targeting adenovirus with use of constrained peptide motifs
US6111166A (en) * 1994-09-19 2000-08-29 Medarex, Incorporated Transgenic mice expressing human Fcα and β receptors
US6127525A (en) * 1995-02-21 2000-10-03 Cornell Research Foundation, Inc. Chimeric adenoviral coat protein and methods of using same
US5770442A (en) 1995-02-21 1998-06-23 Cornell Research Foundation, Inc. Chimeric adenoviral fiber protein and methods of using same
AU701654B2 (en) * 1995-06-07 1999-02-04 Medarex, Inc. Anti-allergy bispecific molecules
US6783980B2 (en) 1995-06-15 2004-08-31 Crucell Holland B.V. Packaging systems for human recombinant adenovirus to be used in gene therapy
US5922845A (en) * 1996-07-11 1999-07-13 Medarex, Inc. Therapeutic multispecific compounds comprised of anti-Fcα receptor antibodies
US20030017138A1 (en) 1998-07-08 2003-01-23 Menzo Havenga Chimeric adenoviruses
US6929946B1 (en) 1998-11-20 2005-08-16 Crucell Holland B.V. Gene delivery vectors provided with a tissue tropism for smooth muscle cells, and/or endothelial cells
US6913922B1 (en) 1999-05-18 2005-07-05 Crucell Holland B.V. Serotype of adenovirus and uses thereof
US6492169B1 (en) 1999-05-18 2002-12-10 Crucell Holland, B.V. Complementing cell lines
CA2381565A1 (en) * 1999-07-30 2001-02-08 Medarex, Inc. Therapeutic compounds comprised of anti-fc receptor binding agents
US20010051147A1 (en) * 2000-03-27 2001-12-13 Van De Winkel Jan G.J. Methods for immunostimulation using binding agents for the Fc receptor of immunoglobulin A
US7235233B2 (en) 2000-09-26 2007-06-26 Crucell Holland B.V. Serotype 5 adenoviral vectors with chimeric fibers for gene delivery in skeletal muscle cells or myoblasts
MXPA03007144A (es) 2001-02-12 2004-04-02 Medarex Inc Anticuerpos monoclonales humanos para receptor fc alfa (cd89).
ES2335657T3 (es) 2002-04-25 2010-03-31 Crucell Holland B.V. Medios y metodos para la produccion de vectores de adenovirus.
US20060165675A1 (en) * 2002-08-02 2006-07-27 Richman-Eisenstat Janice Beth Modulation of mesenchymal cells via iga-receptors
AU2005302312A1 (en) * 2004-10-29 2006-05-11 Elusys Therapeutics, Inc. Use of CR1-binding molecules in clearance and induction of immune responses
EP2127666A1 (en) * 2008-05-28 2009-12-02 Drug Discovery Factory B.V. Method for the treatment or prophylaxis of chronic inflammatory diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4676980A (en) * 1985-09-23 1987-06-30 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Target specific cross-linked heteroantibodies
US4954617A (en) * 1986-07-07 1990-09-04 Trustees Of Dartmouth College Monoclonal antibodies to FC receptors for immunoglobulin G on human mononuclear phagocytes

Also Published As

Publication number Publication date
ES2132072T3 (es) 1999-08-16
EP0496818A1 (en) 1992-08-05
EP0496818B1 (en) 1999-06-23
CA2067244A1 (en) 1991-04-21
ATE181558T1 (de) 1999-07-15
JPH05504677A (ja) 1993-07-22
CA2067244C (en) 2000-12-19
US5610057A (en) 1997-03-11
DE69033181T2 (de) 1999-10-21
DE69033181D1 (de) 1999-07-29
WO1991005805A1 (en) 1991-05-02

Similar Documents

Publication Publication Date Title
DK0496818T3 (da) IgA-receptor-specifikt monoklonalt antistof
DE69032979D1 (de) Bispezifische heteroantikörper mit zweifachen effektorfunktionen
ATE169031T1 (de) Zellrezeptor spezifische monoklonale antikörper gegen stammzell-faktor-rezeptor
DK180380A (da) Hybrid cellelinie og fremgangsmaade til fremstilling og anvendelse deraf
EP0867189A3 (en) Monoclonal antibodies reactive with defined regions of the T cell antigen receptor
LU91219I2 (fr) Omalizumab (anticorps humanisé recombinant anti-ige)
ATE170562T1 (de) Ctl4a rezeptor, ihn enthaltenden fusionsproteine und deren verwendungen
IL61863A (en) Monoclonal antibody to a human monocyte antigen,its production and diagnostic and pharmaceutical compositions contaiing it
NO802751L (no) Hybrid cellelinje for fremstilling av monoclonalt antistoff til cytotoksiske og suppressor t-celler hos mennesker, samt fremgangsmaate til fremstilling av antistoffet
WO2001090151A3 (en) Human receptor proteins; related reagents and methods
IL123736A0 (en) Tryptase polyclonal antibody and purification method for use in human immunoassay
DK0749481T3 (da) Humaniserede monoklonale antistoffer mod human interleukin-4
WO1999046379A3 (en) Human receptor proteins; related reagents and methods
FI900230A0 (fi) Anti-idiotypa antikroppar mot antikroppar mot antigener med hoeg molekylvikt associerade till human melanoma.
EP0396505A3 (en) Monoclonal antibodies specific for an immunoglobulin isotype
YU13392A (sh) ANTITELA NA HUMANI RECEPTOR ZA IgE
AU629954B2 (en) Monoclonal antibodies directed against activated microglial cells, hybridomas secreting these monoclonal antibodies, antigen recognized by these monoclonal antibodies and their applications
NO972522L (no) Monoklonale antistoffer med immunoundertrykkende aktivitet
ATE207935T1 (de) Antikörper gegen ein, einen histidin-anteil aufweisendes fusionspolypeptid
AU3717889A (en) Monoclonal antibody recognizing gamma atrial natriuretic polypeptide
FR2599513B1 (fr) Anticorps monoclonaux inhibant la liaison de ige soluble aux lymphocytes humains, hybridomes monoclonaux produisant de tels anticorps, leur utilisation
WO1999019480A3 (en) Human receptor proteins; related reagents and methods
FI974018A (fi) Ihmisen 2 integriini -alayksikkö
EP0370090A4 (en) Immunogens and biologically active peptides derived from shared sequences from antigens and anti-idiotypic antibodies or antibodies specific for cellular receptors of the antigens
Chen et al. Antigenic characterization of HIV-1 gp41 binding proteins